Wataru Nishi

6PUBLICATIONS
14CO-AUTHORS
Medical biochemistry - lipidsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 16, 2026
Cholesterol maintains the degradative capacity of lysosomes during clearance and recycling of dysfunctional mitochondria.

|Jan 08, 2026
PD-1 suppresses CAR signaling by forming the inhibitory signalosome colocalizing to CAR microclusters.

Yosuke Yoshida, Hiroaki Machiyama, Ei Wakamatsu

|Oct 30, 2025
CD28-mediated linear and parallel costimulatory signaling cooperatively regulate CAR-T cell functions via CAR-CD28 microclusters.

Tetsushi Nishikawa, Arata Takeuchi, Hiroaki Machiyama

|Mar 13, 2024
NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer.

Chika Shirakami, Koei Ikeda, Hironori Hinokuma

|Jun 06, 2023
Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters.

Wataru Nishi, Ei Wakamatsu, Hiroaki Machiyama

|May 15, 2021
PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment.

Tomohiro Takehara, Ei Wakamatsu, Hiroaki Machiyama

Pageof 1

Frequent Collaborators

4 joint publications

Ei Wakamatsu

4 joint publications

Hiroaki Machiyama

4 joint publications

Tadashi Yokosuka

2 joint publications

Arata Takeuchi